+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Does mitotic rate predict sentinel lymph node metastasis or survival in patients with intermediate and thick melanoma?



Does mitotic rate predict sentinel lymph node metastasis or survival in patients with intermediate and thick melanoma?



American Journal of Surgery 200(6): 759-63; Discussion 763-4



The significance of mitotic rate (MR) in melanoma remains controversial. In this retrospective analysis of a prospective randomized trial that included patients with melanoma of 1.0 mm or greater, all patients underwent wide excision and sentinel node (sentinel lymph node [SLN]) biopsy. Univariate and multivariate analyses were performed to evaluate factors predictive of disease-free survival (DFS) and overall survival (OS). A total of 551 patients had MR reported. A cut-off point of 6 mitoses/mm(2) best discriminated DFS and OS: 455 patients (82.6%) had MR less than 6/mm(2). SLN were tumor-positive in 14.7% of low MR versus 31.3% of high MR patients (P = .0003). There were significant differences in DFS (P = .0014) and OS (P = .0002) between the 2 groups, however, MR failed to remain significant in the multivariate model. MR is weakly predictive of SLN status but it is not an independent predictor of survival for melanomas 1.0 mm or thicker.

(PDF emailed within 0-6 h: $19.90)

Accession: 052691438

Download citation: RISBibTeXText

PMID: 21146017

DOI: 10.1016/j.amjsurg.2010.07.037


Related references

Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients. Annals of Surgical Oncology 22(9): 2978-2987, 2016

Validation of the S classification of sentinel lymph node and microanatomic location of sentinel lymph node metastases to predict additional lymph node involvement and overall survival in breast cancer patients. Annals of Surgical Oncology 18(6): 1691-1697, 2011

Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma. Surgery 130(2): 151-156, 2001

Clinico-pathologic features of primary melanoma and sentinel lymph node predictive for non-sentinel lymph node involvement and overall survival in melanoma patients: a single centre observational cohort study. Surgical Oncology 20(4): 259-264, 2012

Total sentinel lymph node tumor size predicts nonsentinel node metastasis and survival in patients with melanoma. Annals of Surgical Oncology 17(11): 3015-3020, 2011

Can nomograms predict non-sentinel lymph node metastasis after neoadjuvant chemotherapy in sentinel lymph node-positive breast cancer patients?. Clinical Breast Cancer 9(2): 92-95, 2009

Sentinel lymph node status is the strongest independent predictor for disease free and overall survival in patients with thick melanoma. Journal of the European Academy of Dermatology and Venereology 27(11): 1454-1456, 2014

The risk of regional lymph node metastases in patients with melanoma less than 1.0 mm thick: recommendations for sentinel lymph node biopsy. Journal of the American College of Surgeons 197(3): 403-407, 2003

Does the risk of regional lymph node metastases in patients with melanoma less than 10 mm thick justify sentinel lymph node biopsy?. International Journal of Cancer Supplement (13): 406-407, 2002

Sentinel lymph node biopsy is indicated for patients with thick clinically lymph node-negative melanoma. Cancer 121(10): 1628-1636, 2015

Sentinel lymph node status affects long-term survival in patients with intermediate-thickness melanoma. Journal of Cancer Research and Therapeutics 12(2): 840-844, 2016

Validation of a nomogram to predict the risk of non-sentinel lymph node metastasis in breast cancer patients with a positive sentinel node biopsy. European Journal of Cancer Supplements 6(7): 153, 2008

Is the mitotic rate of 1/mm2 the correct cutoff point for performing sentinel lymph node biopsy in pregnant patients with thin melanoma?. Melanoma Research 23(5): 420-421, 2015

Sentinel node metastasis mitotic rate (SN-MMR) as a prognostic indicator of rapidly progressing disease in patients with sentinel node-positive melanomas. International Journal of Cancer (): -, 2016

Factors associated with improved survival among young adult melanoma patients despite a greater incidence of sentinel lymph node metastasis. Journal of Surgical Research 143(1): 164-168, 2007